A citation-based method for searching scientific literature

Maki Miwa, Mikio Nakajima, Richard H Kaszynski, Hideaki Goto. BMJ Case Rep 2020
Times Cited: 3







List of co-cited articles
11 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Prolonged acidosis is a feature of SGLT2i-induced euglycaemic diabetic ketoacidosis.
Mohammed Faraz Rafey, Arslan Butt, Barry Coffey, Lisa Reddington, Aiden Devitt, David Lappin, Francis M Finucane. Endocrinol Diabetes Metab Case Rep 2019
7
100

Euglycemic diabetic ketoacidosis caused by canagliflozin: a case report.
Masafumi Fukuda, Masakazu Nabeta, Takanori Muta, Kei Fukami, Osamu Takasu. Int J Emerg Med 2020
4
66

Sodium-Glucose Linked Transporter Inhibitors as a Cause of Euglycemic Diabetic Ketoacidosis on a Background of Starvation.
Abubakar Tauseef, Muhammad Sohaib Asghar, Maryam Zafar, Noman Lateef, Joseph Thirumalareddy. Cureus 2020
4
66


Euglycemic diabetic ketoacidosis due to a strict low-carbohydrate diet during treatment with sodium-glucose cotransporter 2 inhibitors.
Yuita Fukuyama, Kenji Numata, Kaede Yoshino, Takushi Santanda, Hiraku Funakoshi. Acute Med Surg 2020
8
66

Nephrology Consultation for Severe SGLT2 Inhibitor-Induced Ketoacidosis in Type 2 Diabetes: Case Report.
Felice Nappi, Antonietta La Verde, Giovanni Carfora, Carlo Garofalo, Michele Provenzano, Ferdinando Carlo Sasso, Luca De Nicola. Medicina (Kaunas) 2019
6
66



A Case of Diabetic Ketoacidosis in a Patient on an SGLT2 Inhibitor and a Ketogenic Diet: A Critical Trio Not to Be Missed.
Samantha Steinmetz-Wood, Matthew Gilbert, Katherine Menson. Case Rep Endocrinol 2020
5
66

Clinical characteristics of diabetic ketoacidosis in users and non-users of SGLT2 inhibitors.
J Y Jeon, S-K Kim, K-S Kim, S O Song, J-S Yun, B-Y Kim, C-H Kim, S O Park, S Hong, D H Seo,[...]. Diabetes Metab 2019
11
66




Diabetic ketoacidosis.
R S Israel. Emerg Med Clin North Am 1989
8
33



Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.
Deepak L Bhatt, Michael Szarek, P Gabriel Steg, Christopher P Cannon, Lawrence A Leiter, Darren K McGuire, Julia B Lewis, Matthew C Riddle, Adriaan A Voors, Marco Metra,[...]. N Engl J Med 2021
263
33


Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis : A Multicenter Cohort Study.
Antonios Douros, Lisa M Lix, Michael Fralick, Sophie Dell'Aniello, Baiju R Shah, Paul E Ronksley, Éric Tremblay, Nianping Hu, Silvia Alessi-Severini, Anat Fisher,[...]. Ann Intern Med 2020
26
33



SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis.
Ronald M Goldenberg, Lori D Berard, Alice Y Y Cheng, Jeremy D Gilbert, Subodh Verma, Vincent C Woo, Jean-François Yale. Clin Ther 2016
108
33

Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor.
Michael Fralick, Sebastian Schneeweiss, Elisabetta Patorno. N Engl J Med 2017
146
33


A Case Report: Euglycemic Diabetic Ketoacidosis Presenting as Chest Pain in a Patient on a Low Carbohydrate Diet.
Brenda Dorcely, Juliana Nitis, Arthur Schwartzbard, Jonathan D Newman, Ira J Goldberg, Melissa Sum. Curr Diabetes Rev 2021
4
33

Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin in a Patient with Colon Malignancy.
Eleni Papadokostaki, Evangelos Liberopoulos. Case Rep Endocrinol 2019
6
33

COVID-19-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes on SGLT2 inhibitor: a case report.
Daniel Valente Batista, Carla Antoniana Ferreira de Almeida Vieira, Thomaz Alexandre Costa, Eduardo Gomes Lima. Diabetol Int 2020
6
33

Euglycemic Diabetic Ketoacidosis Precipitated by SGLT-2 Inhibitor Use, Pericarditis, and Fasting: A Case Report.
Rebecca A Mendelsohn, Anabelle N Taveras, Benjamin A Mazer, Lisa M Clayton. Clin Pract Cases Emerg Med 2020
2
50

Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review.
Soulmaz Fazeli Farsani, Kimberly Brodovicz, Nima Soleymanlou, Jan Marquard, Erika Wissinger, Brett A Maiese. BMJ Open 2017
73
33

Euglycaemic diabetic ketoacidosis in a 43-year-old woman with type 2 diabetes mellitus on SGLT-2 inhibitor (empagliflozin).
Azka Latif, Aheli Arce Gastelum, Akshat Sood, Joseph Thilumala Reddy. BMJ Case Rep 2020
1
100

Dehydration and insulinopenia are necessary and sufficient for euglycemic ketoacidosis in SGLT2 inhibitor-treated rats.
Rachel J Perry, Aviva Rabin-Court, Joongyu D Song, Rebecca L Cardone, Yongliang Wang, Richard G Kibbey, Gerald I Shulman. Nat Commun 2019
38
33

Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study.
Guifeng Xu, Buyun Liu, Yangbo Sun, Yang Du, Linda G Snetselaar, Frank B Hu, Wei Bao. BMJ 2018
147
33


Management of hyperglycemic crises in patients with diabetes.
A E Kitabchi, G E Umpierrez, M B Murphy, E J Barrett, R A Kreisberg, J I Malone, B M Wall. Diabetes Care 2001
308
33

Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review.
Erasmia Sampani, Pantelis Sarafidis, Chrysostomos Dimitriadis, Efstratios Kasimatis, Dimitra Daikidou, Konstantinos Bantis, Alexios Papanikolaou, Aikaterini Papagianni. BMC Nephrol 2020
3
33

Use of SGLT-2 inhibitor in COVID-19: A cautionary tale.
Zohaib Yousaf, Waqar Munir, Riyadh Ali Mohammed Hammamy. MedComm (2020) 2021
1
100



Euglycemic Diabetic Ketoacidosis in a Lung Cancer Patient Using Empagliflozin.
Jordan Sexe, Chadwick Mayes, Peter Tofts. Case Rep Crit Care 2020
2
50


Ketoacidosis with euglycemia in a patient with type 2 diabetes mellitus taking dapagliflozin: A case report.
Sang Mok Yeo, Hayeon Park, Jin Hyuk Paek, Woo Yeong Park, Seungyeup Han, Sung Bae Park, Kyubok Jin. Medicine (Baltimore) 2019
6
33



Periprocedural Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter 2 Inhibitor Therapy During Colonoscopy.
Emily J Meyer, Edward Mignone, Anthony Hade, Venkatesan Thiruvenkatarajan, Robert V Bryant, David Jesudason. Diabetes Care 2020
5
33

Dapagliflozin-induced Late-onset Euglycemic Diabetic Ketoacidosis.
Iqra Iqbal, Mohsin Hamid, Muhammad Atique Alam Khan, Aleesha Kainat, Shafaq Tariq. Cureus 2019
7
33

Early detection of euglycemic ketoacidosis during thoracic surgery associated with empagliflozin in a patient with type 2 diabetes: A case report.
Chie Kitahara, Shuhei Morita, Shohei Kishimoto, Shohei Matsuno, Shinsuke Uraki, Ken Takeshima, Yasushi Furukawa, Hidefumi Inaba, Hiroshi Iwakura, Hiroyuki Ariyasu,[...]. J Diabetes Investig 2021
1
100


Euglycemic diabetic ketoacidosis in type 2 diabetes with sodium glucose cotransporter 2 inhibitors.
An-Yi Wang, Sen-Kuang Hou, Shan-Jen Li, Wei-Fong Kao. Am J Emerg Med 2017
4
33

Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus.
Muneerah M Albugami, Mohammed Ahmed, Dhari Alobaid. Saudi J Med Med Sci 2020
1
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.